EURETINA 2024: Kyoko Ohno-Matsui, MD, PhD, shares a keynote on cutting-edge technologies for pathologic myopia

News
Article

How retinal imaging can provide clinicians a deeper understanding of myopia

At this year's European Society of Retina Specialists (EURETINA) meeting, a number of keynote speakers presented on a wide array of topics. Kyoko Ohno-Matsui, MD, PhD, delivered the Euretina Lecture for 2024, titled "Pathologic Myopia: New Horizons through Cutting-Edge Imaging Technologies." In this video interview, she tells Ophthalmology Times Europe about new approaches to ocular imaging for myopia, and looks ahead to future EURETINA meetings.

Editor's note: The below transcript has been lightly edited for clarity.

Kyoko Ohno-Matsui, MD, PhD: Hi, my name is Kyoko Ohno-Matsui. I'm from Tokyo Medical and Dental University, Japan. In my keynote lecture, I talked about cutting-edge technologies for pathologic myopia, and especially, I used ultrawidefield OCT and a novel technology called polarisation-sensitive OCT, or PS-OCT. And, actually PS-OCT visualises scleral collagen fibres, so we can see what's going on in the scleral fibres in human eyes. It's a new technology, and before, just a segment of scleral was possible to see with usual OCT, but with this device, we can differentiate inner and outer layers of sclera, and how different layers of sclera play a role in the pathogenesis of scleral abnormalities.

So this was exciting. In addition, pathological myopia is a deformity of the eye shape. So with 3D MRI, we can see the entire shape of the eye from any angle and how it is deformed in each patient. This information is important, because we may be able to treat the shape of the eye before vision-threatening complications. So I'm very excited to deliver a keynote lecture at this EURETINA conference.

After the lecture, I have had many responses from participants. They say that the images are very stunning. And actually, pathological myopia is a disorder which is suitable for ocular imaging, because that retina choroid sclera is thin. So we can see deeper, and we can see deeper tissue clearly. So it's a benefit for pathological myopia. I like [to] study pathological myopia, because I like imaging too. So I appreciate these responses.

This EURETINA Congress is really exciting, because Europe is a diverse continent with many countries. I really feel the diverse culture when many people get together, and not only from Europe. Americans come, and many Asians are here too. So it's [a] really globally diverse congress, and the programme is well thought out. I see many myopia sessions as well, which I think is new. Before, myopia was thought to be specific to Asian countries, but now it's becoming more prevalent in many areas. So I am glad to see many myopia sessions.

And Barcelona itself is a beautiful city. It has a beautiful beach and port, and I really enjoy the food too. I like the Mediterranean diet, so I'm very happy to be here. I feel very comfortable in this EURETINA congress.

Since this EURETINA congress is very good, and all aspects of retina are presented here, I hope that more and more Asian colleagues should attend. I'm from Japan, but maybe next year we will help more Japanese and more Asians to attend. Truly, it [will be] a global retinal meeting, in the future.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.